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ABSTRACT 
Fluid Flow Characterization and In Silico Validation in a  
Rapid Prototyped Aortic Arch Model 
Alexandra Knauer 
Transcatheter aortic heart valve replacement (TAVR) is a procedure to replace a 
failing aortic valve and is becoming the new standard of care for patients that are not 
candidates for open-heart surgery [2]. However, this minimally invasive technique 
has shown to cause ischemic brain lesions, or “silent infarcts”, in 90% of TAVR 
patients, which can increase the patient’s risk for stroke by two to four times in future 
years [3]. Claret Medical Inc., a medical device company, has developed a cerebral 
protection system that filters and captures embolic debris released during 
endovascular procedures, such as TAVR. This thesis utilized CT scans from Claret 
Medical to create a physical construct of the aortic arch to experimentally validate a 
theoretical computer model through flow visualization. The hypothesis was that the 
empirical model can accurately mimic the fluid dynamic properties of the aortic arch 
in order validate an in silico model using the finite elements program COMSOL 
MultiPhysics® Modeling Software. The physical model was created from a patient 
CT scan of the aortic arch using additive manufacturing (3D printing) and polymer 
casting, resulting in the shape of the aortic arch within a transparent, silicone material. 
Fluid was pumped through the model to visualize and quantify the velocity of the 
fluid within the aortic arch. COMSOL MultiPhysics® was used to model the aortic 
arch and obtain velocity measurements, which were statistically compared to the 
velocity measurements from the physical model. There was no significant difference 
between the values of the physical model and the computer model, confirming the 
hypothesis. Overall, this study successfully used CT scans to create an anatomically 
accurate physical model that was validated by a computer model using a novel 
technique of flow visualization. As TAVR and similar procedures continue to 
develop, the need for experimental evaluation and visualization of devices will 
continue to grow, making this project relevant to many companies in the medical 
device industry. 
 
Keywords: Computer model validation, 3D printing, aortic arch, TAVR, transcatheter 
aortic valve replacement, additive manufacturing, rapid prototyping, COMSOL 
MultiPhysics®
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CHAPTER 1: INTRODUCTION 
1.1 Purpose and Background 
 Every year, more than five million Americans are diagnosed with heart valve 
disease, the most common affecting the aortic valves [1]. Transcatheter aortic heart valve 
replacement (TAVR) is a procedure to replace a failing aortic valve and is becoming the 
new standard of care for patients that are not candidates for open-heart surgery [2]. 
However, this minimally invasive technique has shown to cause ischemic brain lesions, 
or “silent infarcts”, in 90% of TAVR patients. This can increase the patient’s risk for 
stroke by two to four times in future years [3].  
While TAVR is a minimally invasive procedure, the high risk of silent cerebral 
lesions and the risk of stroke can be life threatening for a patient. Claret Medical Inc., a 
medical device company, has developed a cerebral protection system that filters and 
captures embolic debris released during endovascular procedures, such as TAVR. The 
device is used globally, though is not yet commercially available in the United States [4]. 
Previous studies by Andrew Janicki (2015) used CT scans from Claret Medical to track 
particulates within the aortic arch using COMSOL MultiPhysics®, a finite element 
analysis computer-modeling program.  
 This project will utilize the same CT scans from Claret Medical to create a 
physical construct. The goal is to create a construct that can be used to experimentally 
validate the theoretical computer model through flow visualization. As TAVR and similar 
procedures continue to develop, the need for experimental evaluation and visualization of 
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devices will continue to grow, making this project relevant to many companies in the 
medical device industry. 
 
1.2 General Approach 
 This study has three aspects: a physical model, a computer simulation, and flow 
visualization experiments. The physical model of the aortic arch will be created from a 
patient CT scan of the aortic arch. The CT scan will be converted to an STL file, 3D 
printed, and cast with an optically clear rubber. This will create the shape of the aortic 
arch within an enclosed, transparent material that can be used to visualize and 
characterize the flow of fluid within the aortic arch. 
 The COMSOL MultiPhysics® model of the aortic arch, first evaluated by Janicki 
(2015), will be modified to improve the model’s accuracy. Current modifications defined 
by Janicki are improvement of the STL file and a change in the fluid viscosity within the 
model. Additional modifications of the model will be defined through evaluation of the 
previous work and further development of the project. 
 The final aspect of this thesis is flow visualization within a physical aortic arch 
model. Fluid will be pumped in the physical model and dye will be injected and evaluated 
to quantify the flow within the arch. The output of the flow within the physical model 
will be compared to the output of the COMSOL MultiPhysics® model for statistical 
significance. 
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1.3 Study Aims 
The specific aims of this study are as follows: 
i) To create a three-dimensional, physiologically accurate construct of the aortic 
arch using additive manufacturing techniques for the purpose of clinical 
testing. 
ii) To improve a predictive COMSOL MultiPhysics® model of blood flow 
conditions within the aortic arch. 
iii) To validate a model in COMSOL MultiPhysics® model through comparison 
to the fluid dynamics in an empirical model.  
 
The hypothesis of this study is that the empirical model can accurately mimic the fluid 
dynamic properties of the aortic arch found in the human body as well as validate an in 
silico model using the finite elements program COMSOL MultiPhysics® Modeling 
Software.  
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CHAPTER 2: BACKGROUND & RELATED STUDIES 
2.1 Anatomy and Clinical Relevance 
 The aortic arch carries blood from the heart to the rest of the body, first branching 
from the top of the arch. The most common anatomy of the aortic arch (Figure 1) has, 
from left to right, the first branch of the innominate (or brachiocephalic) artery, the 
second branch of the left carotid artery, and the third branch of the left subclavian artery. 
With respect to Figure 1, blood travels from the heart on the left to the descending aorta 
on the right or to the branching vessels [5].  
 
Figure 1. Typical aortic arch anatomy with branching arteries. 
 
In this anatomy, blood that travels into the brachiocephalic artery bifurcates into the right 
common carotid and the right subclavian arteries. The right subclavian flows into the arm 
and the right common carotid flows into the cerebral circulatory system. Blood that 
travels into the left common carotid artery flows into the cerebral circulatory system. 
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Finally, the left subclavian artery bifurcates into the vertebral artery, leading to the 
cerebral circulatory system, and the left subclavian artery [J]. 
The second most common pattern of human aortic arch anatomy is the “bovine 
arch”, as shown in Figure 2. This arch anatomy has a common origin for the 
brachiocephalic artery and the left common carotid artery. 
 
 
Figure 2. The "bovine arch" anatomy with innominate and left common carotid arteries with the same 
origin. 
 
Other variations of the aortic arch occur with different branching patterns and distances 
between artery origins [5]. While there is no “standard arch”, the anatomy of the aortic 
arch with three, distinct branching vessels is seen in about 70% of individuals [5, 6].  
 The aortic valve controls blood flow to the aortic arch; blood is pumped from the 
lungs, to the left atria, to the left ventricle, through the aortic valve and into the aortic 
arch. The valve, as seen in Figure 3, separates the heart from the aortic arch, and 
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subsequently the rest of the body. The purpose is to maintain one-way blood flow out of 
the heart and into the aortic arch. The aortic valve opens when the left ventricle contracts 
and closes when the left ventricle relaxes, obstructing blood from flowing back into the 
heart [13].  
 
 
Figure 3. Anatomy of the heart with the aortic valve leading to the aortic arch.[7] 
 
 There are two main types of aortic valve disease that can affect blood flow 
through the aortic valve: stenosis and regurgitation [8]. Stenosis is when the valve does 
not open entirely and the blood is obstructed from leaving the heart [9]. Regurgitation is 
when the valve does not close completely after blood is pumped out of the heart, allowing 
blood to leak backwards.  Both abnormalities can be congenital or acquired; patients are 
either born with a valve abnormality, for instance with only two cusps instead of the 
normal three, or the patient’s valve leaflets become calcified and develop scar tissue that 
limits the opening and closing of the valve [9].  
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 Patients with aortic valve disease show symptoms such as shortness of breath, 
chest pain, dizziness, or loss of consciousness. The symptoms are due to the narrowed or 
leaky valve causing improper blood flow. Left untreated, aortic valve disease can lead to 
hypertrophy of the left ventricle and potentially sudden death [8, 9]. Symptomatic aortic 
stenosis, if left untreated, has an annual mortality of 25% and an average survival rate of 
2 to 3 years [10]. Currently, there is no medication that can cure aortic valve disease and 
it is most often treated with surgery.  
 The three most common surgeries are aortic valve repair, surgical aortic valve 
replacement, and transcatheter aortic valve replacement [8,10]. The risk factors affecting 
a doctor’s surgical decision include the severity of the valve disease, age, general health, 
and whether other heart surgery procedures are required for the patient at that time [11]. 
Repair of the aortic valve can be done by adding tissue to support the valve, removing or 
reshaping tissue, or separating fused valves [11]. While valve repair is preferred, as it 
preserves the function of the heart muscle, not all valves can be repaired, as is often the 
case with the aortic valve [11]. Valve replacement requires replacing the aortic valve with 
a man-made or biological valve through surgical aortic valve replacement or transcatheter 
aortic valve replacement surgery.  
 Surgical aortic valve replacement (SAVR) is the most common treatment for 
aortic valve disease and is an open-heart procedure. During the procedure, the surgeon 
creates a 6- to 8- inch incision down the center of the sternum to remove and replace the 
diseased valve [12,18]. The procedure typically takes a few hours and involves using a 
heart-lung (bypass) machine through an incision in the chest.  
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Transcatheter aortic valve replacement (TAVR) is an alternative to SAVR and 
currently indicated for patients that have high surgical risk and are not candidates for 
open-heart surgery. Specifically, TAVR was developed for patients with severe 
symptomatic aortic stenosis who have an unacceptably high estimated surgical risk [15].  
The indication could expand to lower surgical risk patients in near future, although 
SAVR is still the standard treatment of care for low risk patients [14]. Transcatheter 
aortic valve replacement is less invasive and allows a new valve to be inserted within the 
native, diseased aortic valve. It does not require a bypass machine and the surgery is 
performed using a catheter through a small incision. The most common type of TAVR is 
through transfemoral approach, using a small incision in the patient’s leg to access the 
heart. The delivery system carries the valve to the heart and the aortic valve; when the 
valve is expanded, typically through a balloon delivery system, the new valve is placed 
over the diseased valve [16]. The valve is secured and immediately replaces the diseased 
valve, as shown in the procedure outline in Figure 4. 
 
 
Figure 4. The TAVR procedure outlined. A) The valve is inserted into the aortic valve through a catheter. 
B) The balloon is expanded over the diseased valve. C) The new valve is expanded and placed over the 
diseased valve. 
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2.2 Complications of TAVR 
 In recent studies, TAVR has shown safety, efficacy, and non-inferiority to 
conventional surgical aortic valve replacement (SAVR).  In a study published in 2012, 
TAVR was shown to reduce the rates of death and hospitalization for patients that were 
not candidates for surgery. Data from 2-year outcomes showed patients had a 25 percent 
decrease in death from any cause, a 50 percent decrease in heart related death, and a 
significant improvement in symptoms [18].  Currently, TAVR is approved in the United 
States for extreme risk or inoperable patients. Trials are being conducted in Europe for 
intermediate risk patients and initial results have shown equivalency to SAVR [19]. A 
study published in 2016 compared TAVR to SAVR in a randomized study in lower-risk 
patients with severe aortic valve stenosis. The reported two-year outcome showed TAVR 
to be safe and effective for lower risk patients [20].  
Though TAVR has shown to be beneficial for patients that are at high risk, 
complications such as paravalvular leak and stroke risk have been associated with TAVR 
in comparison to SAVR [20]. Specifically concerning stroke risk, randomized studies 
have shown a significantly higher stroke rate after TAVR procedures as opposed to 
SAVR [21]. For both procedures, strokes are considered to be embolic (as opposed to 
ischaemic or haemorrhagic); the mechanism and risk occurs during the insertion of a new 
valve. When the new valve is replacing the diseased or calcified valve, there is a risk of 
material being dislodged and traveling to other parts of the body. This can include the 
branching brachiocephalic and left carotid arteries on the aortic arch, leading to the 
cerebral system and potentially causing stroke complications [22]. In the case of TAVR, 
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the calcified or diseased valve remains in the body and mechanism of the atheroemboli or 
calcified material is thought to be during balloon predilation, valve positioning, or valve 
implantation, mechanisms which are not present during SAVR [21,22]. 
While stroke rate is declining for TAVR as technology continues to improve, in 
recent studies decreasing from 7 to 1.7-4.8%, the embolization of debris is still a concern 
for TAVR procedures [21]. Silent cerebral lesions were detected in 68-93% after TAVR 
and 38-54% after SAVR [21]. Silent cerebral lesions, or silent ischaemic infarctions, are 
defined as brain lesions that are a result of a vascular occlusion and are often only 
detected through magnetic resonance imaging (MRI) [23]. Unlike strokes, patients with 
silent cerebral lesions do not show immediate symptoms. While data is varying regarding 
the correlation between silent cerebral lesions and neurocognitive function [21], silent 
cerebral lesions have been linked to progressive brain damage and as a precursor to 
symptomatic strokes [23]. Due to the significantly high rate of silent cerebral lesions 
complicating TAVR procedures, medical device companies have recognized these risks 
and have developed cerebral protection systems. The purpose of these devices, such as 
Claret Medical’s Sentinel Cerebral Protection System (CPS) is to reduce brain embolism 
by filtering or deflecting debris [23].  
 
2.3 Claret Medical’s Sentinel Cerebral Protection System 
Claret Medical is a medical device company founded in 2009 and located in Santa 
Rosa, California. The company has developed the Sentinel ™ Cerebral Protection System 
(CPS) with the purpose of reducing stroke risk during interventional cardiology and 
cardiovascular procedures. The device is indicated for TAVR procedures as well as in 
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thoracic endovascular aneurysm repair (TEVAR), left atrial appendage occlusion 
(LAAO), and transcatheter mitral valve replacement [24]. The Sentinel CPS is “the only 
device designed to protect the brain from the risk of stroke by filtering, capturing, and 
removing debris dislodged during certain interventional and surgical cardiovascular.” 
[24] The Sentinel CPS is currently an investigational device in the United States and is 
undergoing clinical trials.  
The Sentinel CPS is comprised of two embolic filters made of polyurethane film 
with laser-drilled holes, mounted on self-expanding nitinol loops, and delivered through a 
catheter. The device is inserted through the radial artery in the right arm and the filters 
are placed within the brachiocephalic artery and the left common carotid artery during 
procedures, as shown in Figure 5.  
 
 
Figure 5. Claret Medical Sentinel Cerebral Protection System is placed within the brachiocephalic artery 
and the left common carotid artery. [25] 
 
The filters collect any debris released during a procedure and prevent debris from 
traveling through the brachiocephalic artery and the left common carotid, and 
consequently the head and neck. The debris can include valve tissue, calcification, or 
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thrombus that is dislodged at any point during the procedure. In the example of TAVR, 
once the valve is placed and the procedure is completed, the filters and collected debris 
are recaptured into the catheter and removed from the patient [26]. In initial clinical trials, 
Claret has shown a 65% reduction in the total volume of new brain lesions and a 57% 
reduction in the number of new brain lesions 7 days after the procedure [27]. 
 
2.4 CT Scans for Device Testing 
 A significant difference between procedures for the surgical aortic valve 
replacement (SAVR) and transcatheter aortic valve replacement (TAVR) is in the 
visualization of the patient’s anatomy. In SAVR, there is direct, open access to the 
anatomy that allows for visual evaluation of the aortic arch and aortic valve. TAVR lacks 
open access and requires different methods of visualization during the procedure. 
Techniques such as echocardiography, computed tomography, and fluoroscopy are used 
to understand the aortic geometry for device selection and placement [28]. 
 Prior to TAVR, patients undergo assessment of the aortic root anatomy and the 
coronary and iliofemoral arteries to evaluate the feasibility of the procedure [29]. The 
diagnostics include echocardiography, cardiac catheterization, aortioilliac angiography, 
transcatheter heart valve sizing, and computed tomography (CT) scans [29]. Of those 
methods, CT scans have been increasingly recognized as an optimal method to address 
the evaluation of the surgical geometries and image for TAVR.  
 Due to varying anatomies, TAVR must be individualized for a patient [29]. For 
example, the sizing of the catheter for transfemoral access is key to the success of the 
procedure. As shown in Figure 6 of a CT angiographic image, the image reveals an area 
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in the right external iliac artery that would inhibit endovascular access, as indicated by 
the arrow. 
 
 
Figure 6. CT angiographic image showing the right external iliac artery (arrow) that would inhibit 
endovascular access. [30] 
 
In this example, the patient would not be a likely candidate for transfemoral TAVR as the 
patient’s femoral artery could be incompatible with a femoral catheter. This does not 
necessarily disqualify a patient from TAVR, but is a risk factor that needs to be taken into 
consideration.  
 Conventional angiography allows for basic assessment of the luminal size, though 
it is not suitable for morphologic features. CT is considered a valuable tool to determine 
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the presence and amount of anomalies such as atherosclerotic calcifications and can 
determine patient eligibility, access strategy, and prosthetic valve selection [29]. 
 While CT scans are useful for initial analysis, this method of imaging can be 
further applied to three-dimensional analysis by converting the file. Programs such as 
Mimics and OsiriX, can convert the CT scan into a different file format that is compatible 
with computer-aided design (CAD) programs. A common application is the conversion of 
a CT scan to a stereolithography (STL) file, which is a triangulated representation of a 
three-dimensional object’s surface [31]. The file format is widely compatible with 
programs related to CAD, rapid prototyping, and 3D printing. By converting a CT scan 
into an STL file, or similar file format, the patient’s anatomy can be analyzed in a variety 
of programs and is available for more applications, such as 3D printing and creating 
models for physicians to visualize patient anatomy.  
 
2.5 Existing Vascular Constructs and 3D Printing in Clinical Applications 
 Physical models are widely used in the biomedical field for applications from 
physician training to marketing, to device testing. Vendors such as Elastrat, United 
Biologic Silicone Vasculature, and DialAct Corporation manufacture anatomical models 
based on engineering approximation, CAD files, or patient specific data [32,33,34]. 
While these models are widely used, rapid prototyping is a popular as a method of 
prototyping models and visualizing patient anatomy. 
The fundamental purpose of 3D printing is to create a rapid prototype of a model 
through additive manufacturing. Fused Deposition Modeling (FDM) was originally 
developed by Statasys and has become one of the most popular rapid prototyping 
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techniques [35]. FDM works by horizontally depositing molten thermoplastic material, 
extruded from a nozzle. The material is deposited layer-by-layer based on a 3D CAD data 
file, filling each layer of the object (Figure 7). 
 
 
Figure 7. Diagram of FDM rapid prototyping. 
 
The liquefied filament cools after being laid down prior to the nozzle depositing the 
following layer of filament. The nozzle also contains a second filament that provides 
support material for the cooling filament, for features such as overhangs, which is 
removed after printing. A limitation of FDM is that it has a rough finish and often the 
ridges between layers of plastic are visible on the part. Additionally, in a medical 
application the material is rigid does not mimic the properties of biological tissue [36]. 
However, a significant benefit of FDM is the ability to quickly print models at a 
reasonable price from CAD software without additional manufacturing techniques. For 
that reasons, among others, 3D printing has been applied within the medical field. 
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At the Texas Cardiac Arrhythmia Institute, 3D printing was used to recreate 
models of patient’s hearts before performing surgery [37]. The Institute acquired CT 
scans of the patient’s heart and used 3D printing to create transparent models that allowed 
doctors and patients to view internal structures when preparing for a procedure. The 
models were prepared within hours and produced unique patient models to “provide 
customized solutions for improving outcomes [37].” 
Another example was in a study that created personalized brain models. Using 3D 
printing, molding, and casting, the study created a physiologically, anatomically, and 
tactilely realistic model based on magnetic resonance images (MRIs) [38]. The models 
were used to improve surgical training and preoperative planning with the goal of 
providing accurate, customized, high-precision treatment.  
Similar examples exist within the hepatic system, gastrointestinal system, 
musculoskeletal surgeries, and the vascular system [36]. Many hospitals are purchasing 
in-house 3D printers for the purpose of planning complicated procedures, clinical 
training, patient education, and creating customized prosthesis [36]. The prevalence and 
growing popularity of additive manufacturing is applicable to minimally invasive 
procedures, such as TAVR, as the models provide visualization of the anatomy. Within 
biomedical engineering, 3D printing has been used to manufacture products as well as 
test existing products. Models based on patient anatomy have been used in bench top 
testing to develop medical devices and provide safety and efficacy data when applying 
for approval from the FDA. Specifically, the models are used to optimize product design, 
simulate various clinical anatomies, verify the utility of the technology, and perform wear 
testing [39]. 
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2.6 Previous COMSOL MultiPhysics® Modeling Studies 
COMSOL MultiPhysics® is finite element analysis (FEA) software suite that can 
simulate fluid flow, particle tracking, and mechanical stresses. The COMSOL 
MultiPhysics® model of the aortic arch was first evaluated by Andrew Janicki (2015), 
using CT scans and project input from Claret Medical. As this thesis project builds on 
Janicki’s previous work, this section will summarize the past study. Janicki’s study 
additionally built off of thesis studies performed by Ian A. Carr and Shawn Shadden, who 
analyzed the effect of particle size and the path of travel in the aortic arch using 
computational fluid models. 
The purpose of Janicki’s study was to track particles within the aortic arch and 
determine what parameters cause the particles to enter the different branching vessels on 
the aortic arch. The parameters evaluated were particle diameter, particle density, blood 
pressure, and the diameter of the catheter used during TAVR procedures. By using finite 
element analysis in COMSOL MultiPhysics®, Janicki determined that the diameter of the 
catheter was not statistically significant. Additionally, larger particles have a higher 
probability of entering the brachiocephalic artery, the left common carotid artery, and the 
left subclavian artery, while smaller particles would continue in the descending aorta. 
Averaging all particle diameters, densities, and blood pressure outcomes, Janicki 
determined that 54.95 ± 13.66% of the 1,000 particles released would travel into the 
cerebral circulatory system within his model.  
Janicki’s COMSOL MultiPhysics® model used the Creeping Flow module and 
had nine simulations run for 13 seconds with 0.5-second time steps. The results were 
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analyzed using multivariate analysis of variance in JMP Pro 11 statistical software. The 
study used the same CT scan, provided as a stereolithography (STL) file. The original file 
with truncated daughter vessels, as seen in Figure 8, had 61,543 faces within the mesh 
file. 
 
 
Figure 8. Original STL file of the aortic arch with 61,543 faces. 
 
 Janicki used MeshMixer to simplify the model to 251 faces, as seen in Figure 9. The 
geometry, while usable in SolidWorks, was an oversimplification of the original CT scan. 
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Figure 9. The STL file modified on MeshMixer to 251 faces. 
 
While the general shape of the arch remained intact and it reduced computational time, 
the significant reduction of faces caused the model to have sharp sections that are not 
anatomically accurate. This study will re-process the original STL file to have it be more 
anatomically accurate as well as compatible with COMSOL MultiPhysics® and 
SolidWorks. 
David Baik, an undergraduate in the Cal Poly BioFluidics Lab, evaluated creep 
flow and laminar flow within the aortic arch as a part of this thesis study. Creep flow 
versus laminar flow is determined by a fluid’s Reynolds’s number. The Reynold’s 
number describes the ratio of inertial to viscous forces with Equation 1 [40]. 
 
Equation 1:  Re = 	 mnop  
 
Where ρ is the density, U is the characteristic velocity, d is the vessel diameter, and µ is 
the dynamic viscosity. At higher Reynold’s numbers both inertial forces and the Laminar 
Flow module should be used on COMSOL MultiPhysics®; however, Janicki’s  (2015) 
model utilized the Creeping Flow interface, assuming a low Reynold’s number 
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accounting only for viscous forces. In contrast, in Baik’s studies it was determined that 
both inertial and viscous forces were present and that laminar flow is optimal for future 
studies. 
In relation to the current study, Baik and Janicki’s findings are relevant as the 
results use the same original CT scan and concern the development of test methods for 
procedures such as TAVR. Therefore, this study will improve the mesh size and use 
laminar flow. 
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CHAPTER 3: MODEL DESIGN AND METHODS 
3.1 Model Geometry 
The geometry of this model is based on a CT scan obtained from Claret Medical. 
The scan is from a patient that underwent TAVR surgery with Claret’s Sentinel CPS 
device. Therefore, the file used to create this model (physical and COMSOL 
MultiPhysics® models) is from a real patient anatomy. This file was chosen for it’s 
anatomical simplicity and since it has the most common anatomy of the aortic arch. The 
CT scan from the patient was converted to a stereolithography (STL) file by an external 
company for Claret Medical. 
 
3.1.1 STL Processing 
The file was processed using MeshMixer to reduce the number of faces on the 
model and reduce anomalies along the arch.  When opened in MeshMixer, the original 
CT scan had 54,190 triangles within the mesh, as shown in Figure 10.  
 
Figure 10. Original CT scan opened in MeshMixer with 54,190 triangles.  
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While the high number of faces allows the computer to accurately represent the 
biological model, it creates a complexity to that increases computational time and can be 
incompatible with computer programs. Additionally, the high number of faces in the 
original model was not necessary to represent the critical features of the model. By 
simplifying the geometry, it reduced the computational time and made it possible to 
import the model into SolidWorks and COMSOL MultiPhysics®. 
The file was imported into MeshMixer and processed to reduce the number of 
faces, as seen in Appendix A written by Brandon Cohen. The processing focused on 
removing extraneous aspects of the arch that were not pertinent to fluid flow within the 
arch. The number of faces was reduced to 9,488 faces, as seen in Figure 11, and the file 
type was converted to be compatible with SolidWorks. 
 
 
Figure 11. Modified STL file of the aortic arch with 9,488 faces. 
 
3.2 Physical Model Design Concept 
The physical model utilized the modified STL file with 9,488 faces. The goal was 
to create a transparent model of the aortic arch in order to visualize fluid flow. The 
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material selected for the model was polydimethylsiloxane (PDMS), since it is translucent 
and has the ability to capture features at the microscopic level. The material is commonly 
used in the manufacturing of microfluidic chips. As seen in Figure 12, models are 
typically made with PDMS by having a master mold, pouring PDMS over the mold, and 
then removing the PDMS containing a negative of the master mold.  
 
Figure 12. An overview of microfluidics manufacturing methods. 1) A master mold exisits with the shape. 
2) PDMS is poured over the master mold. 3) The PDMS is removed from the master mold, leaving a cavity 
in the shape of the master mold. [41] 
 
The physical model of the aortic arch utilizes a similar molding process. 
However, unlike microfabrication, the aortic arch geometry contains daughter vessels and 
is non-symmetrical, making the release of the PDMS negative a challenge. In order to 
create a negative of the aortic arch, a process was developed that allowed the master mold 
to be removed without damaging the PDMS or altering the shape of the vasculature.  
In a previous thesis project by Daniel Greinke, a dissolvable polymer was cast 
within PDMS to evaluate an iliac aneurysm. The study 3D printed the entire aneurysm 
using water-soluble polyvinyl alcohol (PVA) filament. The full aneurysm model involved 
the following steps (as seen in Figure 13): a triangular box was created using acrylic, blue 
painter’s tape, and caulk to encase the aneurysm. One kilogram of PDMS was poured 
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into the box and the 3D printed part of PLA was floated on top. The PDMS was allowed 
to set before the remainder of the 3D printed part was covered in 1 kg of PDMS and the 
entire model was set. Excess material was cut away from the outlets and the model was 
submerged in hot water with the intention of dissolving the PLA.  
 
Figure 13. An overview of Greinke’s PDMS full mold process. A) the mold is assembled. B) Half of the 
PDMS is poured into the mold and the aneurysm is allowed to “float” on top. C) The remainder of the 
PDMS is poured over the aneurysm. D) The PDMS is allowed to set. E) Excess material is removed. F) 
The aneurysm is submerged in water. G) The water is heated to dissolve the PVA. Source: Greinke 
 
Although the model was submerged in hot water for 6 to 8 hours, it was 
ineffective to completely dissolve the PLA. The model was also submerged for 14 days 
in water that was periodically reheated to 120°F. However, regardless of the water 
temperature and the amount of time the model was submerged, the PLA did not dissolve. 
As seen in Figure 14, the study was unable to obtain a cavity in the shape of the 
vasculature. The study ceased using the full aneurysm model for their experiments. 
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Figure 14. Greinke’s full vessel  construct of an iliac aneurysm after being submerged in hot water. The 
PVA did not dissolve from the PDMS and material remained in the construct. 
 
Despite the previous study not achieving a full vascular model, the study showed 
that PDMS is an optimal material for its ease of use and the clarity for flow visualization. 
For this study, the material needed to be transparent and semi-flexible, yet durable 
enough to withstand the flow visualization tests. Other silicone-based materials were 
considered, including Reynold’s Materials SORTA CLEAR series, SmoothOn Clear Flex 
30 or 50, and SmoothOn Ecoflex. While these materials were feasible, PDMS (Sylgard 
184 Silicone Elastomer Kit) was chosen for the model due to Greinke’s success in having 
a transparent model, the ease of use, and material cost. However, a different method of 
creating a 3D printed model will be used in this study.  
The construction concept is based on having two half constructs bonded together 
to create a cavity of the arch within a transparent material.  The construction had the 
following process (see the following sections for additional detail): 
1) The CT/STL file was simplified in Mesh Mixer and saved as an STL 
2) The arch was imported into SolidWorks and split into two halves 
3) Each half was used to create a box mold within SolidWorks with alignment pins 
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4) The two box halves were 3D printed 
5) Each half was coated with Reynold’s Advanced Materials XTC-3D 
6) PDMS was mixed and poured into each box 
7) The PDMS castings were removed from the 3D printed boxes 
8) A thin layer of PDMS was used to bond the two halves of PDMS 
9) PDMS was removed from the inlets and outlets of the bonded PDMS halves 
10) Tubing and adaptors were press fit into the inlets and outlets of the arch 
 
3.2.1 Proof of Concept Prototyping 
 The concept was to create two half vessels and bond the halves together to create 
a full model of the aortic arch. This method eliminates the need to dissolve PLA and 
build an acrylic box as a mold. Also, this concept allows for the addition of alignment 
pins and guarantee that the dimensions of each mold half are equivalent.  
 Proof of concept prototyping was done using a 3D printed 1-inch cube filled with 
PDMS and with a cylinder through the middle, as seen in Figure 15.   
 
Figure 15. Proof of concept prototyping of the 3D printed mold. 
 
 
 
 
27 
The cylinder was created to test the ability to demold the vessels when using PDMS 
when it is poured directly into the mold. The cube also tested the Reynold’s Advanced 
Materials XTC-3D coating; the coating was applied to the cube’s surface and allowed to 
dry for 24 hours. The purpose of the coating was to smooth the step sizes between the 3D 
printed layers. (Refer to section 3.2.2 for more detailed descriptions of PDMS mixing and 
coating application.) 
 The casting of the cube was removed from the mold using a chisel and hammer to 
break the mold open. The cylinder was cut at one end of the cube and slid out through the 
opposite end. As seen in Figure 16, the proof of concept was successful. 
  
 
Figure 16. Proof of concept PDMS cube with cylindrical cavity. 
 
The cube was transparent, maintained the cylindrical and cube shape without apparent 
damage, and the layer lines were reduced without residue from the XTC-3D coating. For 
these reasons, the 3D printed box concept was applied to the STL file of the aortic arch.  
 The proof of concept cube was also used to assess different bonding techniques 
for PDMS to PDMS. In microfabrication, plasma bonding is used to bond PDMS to 
glass. While the author tested this concept, a study by Eddings et al also showed that 
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using uncured PDMS adhesive demonstrated an improvement in bond strength and 
consistency when compared to oxygen plasma bonding for PDMS to PDMS bonding 
[42]. Based on this study and prototype testing, uncured PDMS was determined to be the 
optimal method to bond the PDMS halves. 
 
3.2.2 SolidWorks Design and 3D Printing 
The arch was imported into SolidWorks and split lengthwise into Part A and Part 
B by inserting a plane and using the Split function. As seen in Figure 17, the green Part A 
and the blue Part B split created two pieces without any detached segments. Each arch 
half was designated as a separate part within SolidWorks. 
 
 
Figure 17. The aortic arch file split lengthwise into Part A (green) and Part B (blue). 
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  The split plane was used to create a 1/4 inch base plane under each part. A box 
was drawn from that plane and alignment pins with alternating directions were drawn for 
Part A and Part B. The alignment markers for Part A and Part B were created to be 
complimentary, making it possible for the halves to interact and align correctly. As seen 
in the sequence of Figure 18, Part A was drawn to have outward pegs on the 3D printed 
part.  
 
   
Figure 18. The sequence of creating the 3D printed box with alignment pins for Part A in SolidWorks. 
 
The box was created to maximize the build space of the 6” by 6” 3D printer as well and 
fully enclose the arch halved. Part B, as seen in Figure 19, was created with the same 
method but with inward alignment pins. The alignment pin was created with a slight 
detent for mold removal purposes.  
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Figure 19. Part B of the aortic arch with inward alignment pins. 
 
For Part A, the brachiocephalic artery did not reach the edge of the box. Since the box is 
being used as a mold, the vessel was extended with an added cylinder in SolidWorks so 
the future cavity would have an outlet, as seen in Figure 20. 
 
  
Figure 20. The added cylinder to Part A to allow the brachiocephalic artery to extend to the edge of the 3D 
printed box. 
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As previously mentioned, the two halves were drawn to interact. As shown in Figure 21, 
Part A and Part B are complimentary and have the same dimensions for the box and the 
alignment pins. 
 
Figure 21. The interaction of Part A and Part B in SolidWorks. 
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Dylan Sigley, a Cal Poly student that privately owns a 3D printer, printed the parts. The 
printer is a Printrbot Simple Metal with a 6 inch by 6 inch build space that prints using an 
additive manufacturing technique with PLA. The program Cura 15.04.6 was used to slide 
the models and generate the code to print the model. Figure 17 shows Part A (left) and 
Part B (right), unaltered after being 3D printed. Part A took 17 hours and 9 minutes to 
print, taking 75.98 meters of filament (or 226 grams). Part A had a build failure towards 
the end of the build, causing the box to be a 1/2-inch shorter than intended. However, it 
did not affect the structure of the aortic arch. Part B took 15 hours and 33 minutes to print 
and took 70.99 meters of PLA filament (or 212 grams). Refer to Appendix B for specific 
printer basic and advanced settings. 
Figure 22. 3D printed boxes of Part A and B. 
 
The inner portion of both parts (the area within the box containing the aortic arch) was 
coated with two layers of Reynold’s Advanced Materials XTC-3D with a paintbrush. The 
coating is intended to be a protective coating for smoothing and finishing 3D parts. The 
coating was mixed by volume with a 2A:1B ratio with 20 milliliters of A and 1 milliliter 
of B. The first layer was allowed to dry 24 hours before applying the second. As seen in 
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Figure 23, the coating made the 3D printed parts appear shiny and filled space between 
the different layers of material. 
 
   
Figure 23. 3D printed boxes of Part A (left) and Part B (right) with Reynold's Advanced Materials XTC-3D 
coating. Part A has an extension piece taped to the top of the box. 
 
Since Part A had a build failure that caused the box to be shorter than intended, a 1/2” 
extension piece was printed and taped to the top of Part A. The piece had the same width, 
length, and thickness as the Part A box, but was only a 1/2” in height. It was superglued 
and then duct taped to extend the height of the Part A box to original height created in 
SolidWorks. The extension piece was necessary for the mold to have the correct volume 
to contain the PDMS. 
 
3.2.3 PDMS and Demolding  
 The polydimethysiloxane (PDMS) used was the Sylgard 184 Silicone Elastomer 
Kit from Dow Corning. The volume of PDMS needed for Part A and Part B was 
calculated using the inner dimensions of the boxes in SolidWorks. The calculated volume 
 
 
34 
was then used to determine the volume needed for a 10A:1B ratio for the PDMS, using 
10 parts of the base material and 1 part of the curing agent material. While the calculated 
volume proved to be a larger volume than needed, as shown in Table 1, it served as an 
initial baseline to predict how much material to purchase. 
 
Table 1. PDMS Volumes Calculated and PDMS Volumes Used 	 Part	A		 Part	B	Total	PDMS	Volume	(ml)	 1208.94		 1051.25		PDMS	Base	(ml)	 1090		 955		PDMS	Curing	Agent	(ml)	 110		 95		Total	Base	Used	(ml)	 885	 675	Total	Curing	Agent	Used	(ml)	 89	 68	
 
The discrepancy between the calculated volume and the volume used for the model is due 
to the volume of the aortic arch. The volume of the arch was not taken into account 
during these calculations since the author intended to acquire and mix extra PDMS. This 
proved to be necessary as 900 milliliters of PDMS were lost when a cracked beaker 
shattered during degassing of the PDMS and the material was not usable. Therefore, 
calculating and purchasing extra PDMS was necessary in creating this model.  
With the exception of material volumes, the process of mixing and pouring for Part A and 
Part B were identical. The PDMS was measured in glass beakers and mixed for 10 
minutes with a paint stick. A vacuum (Figure 24) was using to de-gas the PDMS for 2 
hours. (Due to the high volume of PDMS, the de-gassing took longer than expected. 
Additionally, after the process the author discovered a valve that had not been closed that 
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would have decreased the degassing time.) Meanwhile, Part A and Part B were prepared 
by pressing Scotch tape on all parts to remove dust and debris from the molds.  
 
 
Figure 24. The vacuum used to degas PDMS and remove bubbles. 
 
The purpose of degassing was to remove all oxygen bubbles from the PDMS prior to 
pouring to ensure the material cures translucent. Once the bubbles were no longer visible, 
the PDMS was slowly poured into Part A and Part B. The parts were allowed to cure for 
72 hours at room temperature (Figure 25). 
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Figure 25. Part A (left) and Part B (right) with curing PDMS. 
 
After the PDMS had cured, the models were demolded. Unfortunately, demolding was a 
destructive process; a hammer and chisel were used to break the mold surrounding the 
PDMS and remove the arch halves (Figure 26).  
 
Figure 26. The removal of the PDMS from the 3D printed molds. 
 
The removal of the PDMS from the molds took about two hours. A segment of the arch 
on Part A ripped while it was being demolded (Figure 27) and was mended with PDMS 
between the segments and allowed to dry 24 hours. 
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Figure 27. The ripped section of Part A. 
 
After the halves had been demolded and the rip was repaired, the alignment pins were 
tested and proved to be successful. The two halves of the arch had the same outer 
dimensions, allowing the two halves of the arch to align correctly. The two halves of the 
PDMS casting can be seen in Figure 28. 
 
Figure 28. The PDMS casting of the 3D printed parts with Part A (left) and Part B (right). 
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The halves were bonded together using 10 milliliters of base and 1 milliliter of curing 
agent. The materials were mixed for five minutes, degassed for five minutes, and applied 
to the surfaces of both halves in a thin film. The halves were pressed together and 
aligned, using force distributed evenly on the top surface, as seen in Figure 29. The 
weight applied was approximately 10 lbs. 
 
Figure 29. The halves were bonded by PDMS with applied weight. 
 
Once weight was applied, the model was visually inspected for PDMS leaking into the 
aortic arch cavity. The bonding PDMS was allowed to dry for 48 hours before the weight 
was removed. 
 
3.3 Flow Visualization Set-Up 
For this study, steady-state flow was used to simulate the pumping of blood from 
the heart. While the heart is pulsatile, pulsatile flow was beyond the scope of this study. 
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From a study by Spodick et al, the average resting heart rate of a person is between 50 
and 90 beats per minute, via [44]. The normal stroke volume in the human heart is 70 
mL/beat. Therefore, the cardiac output through the aortic arch can be found for this range 
of normal beats per minute (Equation 3). Cardiac output is given in mL/min, so this is 
converted into US Gallons/min in order to find the correct pump to be used (as seen in 
the conversion in Equation 3). 
 
Equation 2:  𝐶𝑂 = 𝑆𝑉×𝐻𝑅 
Equation 3:  1	𝑚𝐿/𝑚𝑖𝑛 = 0.0158503	𝐺𝑎𝑙𝑙𝑜𝑛𝑠/𝑚𝑖𝑛 
 
From these calculations, the suitable rate for a pump to be used to simulate the heart is 
between 55 to 100 Gallons/hour. A TotalPond Submersible Fountain Pump was chosen 
as it can reach a rate of 102 Gallons/hour when run through 5 feet of tubing and was 
within the project’s budget. The pump has a ½” outlet, therefore tubing with a ½” inner 
diameter was used for the model. 
To connect the pump to the arch construct, a razor blade was used to remove 
PDMS from the model to create a ½ inch inlet of the model. A ½ inch male adapter with 
barbed tubing was then twisted and screwed into the inlet of the aorta. Once placed into 
the arch, the fitting was then adhered to the PDMS with clear silicone caulking. In 
addition to a barbed fitting placed at the inlet, a section of tubing was placed into the 
outlet of the arch to help direct flow at the outlet of the arch. The construct with the inlet 
adaptor and outlet tubing is shown in Figure 30.  
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Figure 30. Physical model with an inlet adaptor and outlet tubing. 
 
The daughter vessels had 3/8” and ½” tubing press fit into each, according to size, 
to drain the aortic arch at the outlets. The entire PDMS construct was placed on a piece of 
acrylic. 
The insertion of the ½” adaptor showed to be detrimental to the model, as the 
space in the PDMS was not large enough for the adaptor and caused the two halves to 
begin to peal apart. Applying pressure with a C-Clamp, as seen in Figure 31, mitigated 
this problem. 
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Figure 31. The halves of the construct became unattached with the addition of adaptor (left) and were fixed 
by applying pressure with a C-Clamp (right). 
 
The model was placed on clear acrylic and elevated (using two 2 foot tall buckets) over a 
light source. The light was placed underneath to properly illuminate the arch for imaging. 
All imaging was done using an iPhone 6, placed over the set-up with a metal stand and 
another piece of clear acrylic. The pump was submerged at the bottom of a bucket filled 
with water. A side view and top view of the set-up are shown in Figure 32. 
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Figure 32. The flow visualization set-up side view (left) and top view (right). 
 
 
However, when the pump was plugged in and water was run through the arch, the 
flow was extremely turbulent. Air bubbles were present throughout the arch and could 
not be removed regardless of tube length or pump settings. Red food coloring were 
injected at the inlet of the pump to better visualize the flow within the arch, as seen in 
Figure 33. 
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Figure 33. Turbulent flow with physiologic conditions within the aortic arch. Red food coloring was used 
to better visualize the fluid flow. 
 
 Two methods were used to improve the fluid flow. First, a second pump was 
purchased for slower fluid flow. The X-Small TotalPond Submersible Fountain Pump 
pumps 70 gallons per hour at 1.5 feet of tubing. This slower flow rate is still within the 
range of the average adult stroke rate of the heart. Second, the arch had an inlet and 
maximum diameter of 1 inch; therefore, the ½” male inlet was removed and 1 inch tubing 
was press fit into the model. Additional adaptors and tubing were purchased to attach the 
1 inch inlet of the arch to the ½ inch outlet of the pump. However, while these 
modifications eliminated the turbulent flow, an air bubble was still present to the right of 
the branching vessels (Figure 34). 
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Figure 34. Fluid flow within the arch with red food coloring. A bubble is present to the right of the 
branching vessels with the slower fluid flow, as indicated by the black box. 
 
The larger inlet eliminated the majority of the air within the cavity of the arch, 
however the loss of fluid from the outlet of the daughter vessels caused a bubble. At a 
stationary and horizontal orientation, the fluid within the arch was not sufficient to fill the 
entire diameter.  
 The bubble was removed by allowing the fluid to fill the arch, plugging the 
outlets of the branching vessels, and inverted the model with the branches plugged. This 
allowed the bubble to flow up the tubing and stay at the connection between the 1” and 
¾” tubing. This method made it impossible to use outlet tubing and the set-up of the 
experiment had to be altered. The arch was placed on plastic sheeting and placed over a 
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bucket. This allowed the author to tilt the arch and still contain the liquid to a small area. 
The arch was illuminated using headlamps, sealed in Ziplock bags, within the bucket. 
The altered, finalized set-up is shown in Figure 35.  
 
  
Figure 35. The finalized flow visualization set-up side view (left) and top view (right). 
 
This method was not consistent, as sometimes the bubble would dislodge itself and travel 
back into the arch. In these instances, the arch was inverted again before injecting dye. 
 The two set-ups were qualitatively compared for lighting within the arch, as seen 
in Figure 36.  
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Figure 36. The original arch set-up (left) and the finalized arch set-up (right). 
 
There was not an improvement in lighting and arch visualization between the original set-
up (left) and the finalized set-up (right). However, the modified set-up allowed the bubble 
to be removed and was adequate for image analysis. Lighting should be improved in 
future studies.  
 
3.3.1 Flow Visualization Trial Methods 
 For each trial, the pump was submerged in a gallon of water and water was 
flowed through the arch. Once flow was established in the model, the bubble was 
removed by plugging and inverting the arch model over the bucket. The arch model was 
returned to a horizontal position and checked for bubbles. An iPhone 6 on “SLO-MO” 
mode was used to record a video of the fluid flow. After the bubble was removed and 
steady flow was established within the model, the iPhone was set to record and 3 
milliliters of red food dye (Liquid Color Cherry Red Shade, Esco Foods Inc.) was 
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injected towards the inlet of the pump. The general flow of dye can be seen in 
screenshots of the video in Figure 36. 
 
   
Figure 37. An example of the flow of dye through the aortic arch model. 
 
The flow rate of the pump was measured at the same height and the same tube 
length as used within the arch. It was assumed that the inlet of the vessel has the same 
flow rate as the outlet of the tubing. Ten trials were conducted to measure how much time 
it takes to fill 1 Liter using the pump, with an average of 13.74 seconds per liter. The inlet 
velocity was calculated using the 1 inch cross section of the inlet, as seen in Appendix C. 
The outlet velocity of the pump and inlet velocity of the model is 0.1436 meters per 
second. 
 
3.3.2 Flow Visualization ImageJ Methods 
The videos from the flow visualization trials were opened in QuickTime 7.2 at 
half size. The video was converted from seconds to frames, each frame representing an 
average of 0.034 seconds per frame. (This value was calculated by taking the average of 
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seconds per video divided by frames per video.) Screenshots were taken from the videos 
every 10 frames (every 0.03 seconds) from the instance of the dye initially entering the 
arch to when the dye filled the arch.  
Each trial was individually imported into ImageJ, an open source image 
processing and analysis software. As shown in Appendix D, the images were converted 
into stacks and a color threshold was set at 130 saturation. Setting a color threshold added 
consistent contrast to the image to determine how far the dye had traveled within the 
arch. The author chose a saturation of 130 as the value selected the majority of the dye 
within the arch and was then applied across all trials for consistency. Some erroneous red 
pixels outside of the arch are visible in some images, as seen in Figure 37, and are due to 
the orange bucket used to catch the water and dye. An example of a trial that had the 
threshold applied can be seen in Appendix E. 
 
 
Figure 38. The dye within the arch that was set with a color threshold in ImageJ. The threshold was also 
applied to the bucket due to the orange color. 
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The red threshold that was not within the arch is not considered dye movement for this 
study and is assumed to be the orange bucket or orange reflection. After the color 
threshold, the images were converted from a stack into individual images and saved for 
analysis. 
 
3.3.3 Flow Visualization Analysis Methods 
 The still images, processed in ImageJ, were used to determine the coordinates of 
the dye front. The coordinates were determined with the following method, which was 
applied to every image of each trial:  
1) Determine an origin (common feature) in COMSOL MultiPhysics® and ImageJ 
2) Find the absolute distance from the origin in x and y coordinates 
3) Convert the distance from pixels to meters  
4) Find the coordinates of the common feature in COMSOL MultiPhysics® 
5) Calculate the velocity between dye front locations 
6) Measure the angle of rotation within ImageJ 
7) Apply the coordinate transformation equations to find COMSOL MultiPhysics® 
equivalent coordinates 
The method was adapted from a procedure developed by Daniel Greinke (2015) and 
Rachel Willis (2016); the velocity and position of the dye front was determined by 
comparing the furthest downstream pixel value to the furthest downstream pixel value on 
the proceeding frame.  
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  The origin was identified as the intersection of the left subclavian artery and the 
aortic arch, as this location could be easily identified in both the physical and computer 
models. The coordinates of that location were identified in COMSOL MultiPhysics® as 
x, y, and z coordinates. This origin point was used to align the coordinate systems and as 
point of reference for the physical model.  
The flow visualization images were imported from each trial into ImageJ stack. A 
scale was applied to convert pixel distances to meters. (Refer to Appendix D for more 
detail.) The origin point was identified within the physical model for each trial and the 
Line Tool was used to measure the distance between the origin point and the pixel that 
had travelled the farthest within the arch model. The x and y coordinates were recorded 
for each image, as the images are a 2-dimensional representation and did not have a z 
coordinate. The absolute coordinates were calculated by subtracting the pixel coordinates 
from the origin coordinates to determine the distance between the two coordinates. From 
the absolute coordinates, the change of position of the dye front was calculated by 
comparing the absolute distance traveled between consecutive frames; the absolute 
distance of the preceding point was subtracted from the absolute distance of the point of 
interest. The change in position was used to calculate the velocity by dividing the change 
in position by the amount of seconds equivalent to ten frames (approximately 0.03 
seconds). The outcome of this sequence were values of x and y for the experimental 
model in terms of absolute coordinates and velocity. 
 The angle of rotation of the experimental model was measured in ImageJ for each 
trial. The angle of rotation was defined as the shift in the physical model in relation to the 
frame of the image. The physical model was compared to the frame of the image to check 
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whether it was parallel. If the model was not parallel to the image frame, the Angle Tool 
was used to measure the degree of rotation of the physical model in relation to the image 
frame. The value was converted to radians and used to relate the experimental model to 
the COMSOL MultiPhysics® model. 
 The pixel coordinates were transformed to COMSOL MultiPhysics® coordinates 
using the coordinate transformation equations, Equations 6 and 7, adapted from studies 
by Greinke and Willis, as shown below: 
Equation 6: 𝑥(.) = [ 𝑥 − 𝐶d ∗ 𝑐𝑜𝑠𝜃 − 𝑦 − 𝐶i ∗ 𝑠𝑖𝑛𝜃 ] + 𝐶d 
Equation 7: 𝑦(.) = [ 𝑥 − 𝐶d ∗ 𝑠𝑖𝑛𝜃 + 𝑦 − 𝐶i ∗ 𝑐𝑜𝑠𝜃 ] + 𝐶i 
Where xrot and yrot represent the coordinates in the COMSOL MultiPhysics® model, x and 
y represent the coordinates of a point of interest in the image (after conversion to meters 
and calculations), Cx and Cy represent the COMSOL MultiPhysics® origin coordinates, 
and θ represents the angle of rotation measured from the experimental model. The origin 
point made it possible to relate the two coordinate systems, as COMSOL MultiPhysics® 
does not have a clear method of establishing a customized coordinate system. 
 The output from the overall sequence were x and y coordinates within COMSOL 
MultiPhysics® that represented the farthest moving pixel within the model as well as the 
associated velocities. These coordinates were input into the COMSOL MultiPhysics® 
model to compare velocity measurements. 
 
3.4 COMSOL MultiPhysics® Model Validation Methods 
 The computer model was created using a student license of COMSOL 
MultiPhysics® 4.4, which is a finite element analysis (FEA) multiphysics software suite 
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that can simulate fluid flow, particle tracking, and mechanical stresses. The geometry was 
simplified in MeshMixer and opened in SolidWorks 2011 as a solid part. Prior to being 
imported to COMSOL MultiPhysics®, SolidWorks was used to create inlet and outlet 
planes on the arch using the “Cut with Surface” function within Solidworks (Figure 38).  
 
Figure 39. SolidWorks was used to create flat, planar inlets and outlets of the arch. 
 
The plane slice created single surfaces at each of the inlets and outlets of the arch, as 
opposed to multiple faces. The sliced arch was saved as an IGES and imported into 
COMSOL MultiPhysics® as the model geometry. The imported geometry was scaled (as 
dimensions were lost in the resaving of the file) and moved to have positively scaled axis.  
 Within the imported geometry, the coordinates of the empirical model were 
plotted as point geometries in the COMSOL MultiPhysics® model; for every physical 
model coordinate, a point geometry was inserted into the model. Due to the planar cutting 
in SolidWorks, some points were beyond the inlets and outlets of the COMSOL 
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MultiPhysics® model and were omitted in the study. As the coordinates from the 
physical model were 2-dimensional, having been acquired from still images, an array was 
created for each point in the z-direction. Using x and y coordinates from the physical 
model, the array spanned the width of the vessel in the z-direction with a point every 1 
mm. An example of three point arrays can be seen in Figure 39. 
 
 
Figure 40. An example of a point array in the COMSOL MultiPhysics® model. 
 
The point arrays were used to acquire point evaluations of the velocity within the arch. 
The data was exported to Microsoft Excel and the average velocity was determined 
across the array, based on the assumption that the velocity from the physical model also 
describes the average velocity across a path length. This allowed for a direct comparison 
of a single value of the velocity within the COMSOL MultiPhysics® model and the 
velocity in the physical model. 
 As this study is validating the physical model, fluid properties of water were used 
within COMSOL MultiPhysics® with a Newtonian viscosity of 0.89 cP and a density of 
1000 kg/m3. The model assumes a solid conduit with a no-slip condition at the conduit 
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surface as well as a shear rate of zero at the centerline, where the fluid is at maximum 
velocity. Laminar flow was selected for the study based on a Reynold’s number of 3647, 
as calculated with Equation 1 and indicated by Table 2. The equation of laminar flow is 
as seen in Equation 4, accounting for both inertial and viscous forces in the model. 
 
Equation 1: 𝑅𝑒 = 	 %&'()*+,	-.(/'01*0/.20	-.(/'0 = 	 3456  
Equation 4: 𝜌 N1N) + 𝑣 ∙ 	∇𝑣 = 	∇ ∙ 𝑇 + 𝜌𝑔 
 
Table 2. Flow Regime According to Reynold's Number 
Re << 1 Re < 2100 Re > 4000 
Stoke’s Flow [N] Laminar Flow [N] Turbulent Flow [N] 
 
 
The inlet was identified as the area shown in Figure 40 and the outlets were 
identified as the three branching vessels and the section of the arch leading towards the 
thoracic aorta. 
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Figure 41. The arch inlet in COMSOL MultiPhysics®, as seen in the purple selection. 
 
The initial conditions matched that of the physical model with an inlet velocity of 0.1436 
m/s, as was measured during the empirical trials, and a viscosity of 0.89 cP (μ). The 
pressure change within the model was calculated using the Hagen-Poiseuille equation 
(Equation 5) to be approximately 1.388 Pascal. 
Equation 5:  𝑄 = 	 VWX(Z[\Z])_6`  
The calculated pressure change assumed gauge pressure, in which the outlet equivalent to 
0 Pascal to account for atmospheric pressure within the pressure change. Additionally, 
the inlet (R) is assumed to be 1 inch in diameter and the arch length (L) is assumed to be 
in center of the arch at approximately 8.62 inches.  
 A “Fine Mesh” was used in the model, as it was the highest number of elements 
that could be used without crashing COMSOL MultiPhysics®. The mesh statistics are 
seen in Figure 41. 
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Figure 42. COMSOL MultiPhysics® mesh statistics. 
 
The study was run using a Stationary Study to output velocity and shear stress values as 
well as qualitative graphs to describe the fluid properties. 
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CHAPTER 4: DATA COLLECTION AND RESULTS 
4.1 Flow Visualization Results  
 The physical model yielded both qualitative and quantitative results. 
Qualitatively, the model was successful as an anatomically accurate cavity was created 
within the model and there was no lateral leakage of fluid within the model. Additionally, 
the model was transparent and allowed for quantitative analysis. 
Five trials dye trials were conducted, three of which were analyzed in this study. 
Two trials were not analyzed; Trial 4 had poor lighting (which did not allow for 
thresholding of the image) and Trial 5 had a very large bubble and the frame was shifted 
as the dye ran through the vessel. From those trials, 24 coordinates were determined and 
21 path-length velocities were calculated.  
 
4.2 COMSOL MultiPhysics® Data Collection 
 The COMSOL MultiPhysics® model used 15 of the coordinates calculated from 
the physical model. Due to the planar slicing of the model needed to create inlets and 
outlets, 9 of the coordinates were outside of the geometry of the COMSOL 
MultiPhysics® model. (In future models choosing a different location to initialize and 
end the dye front can mitigate this discrepancy. As consistent initial locations were used 
between the trials, a few points were unusable from every trial.) As previously 
mentioned, an array was created in COMSOL MultiPhysics® and used to find the 
average velocity at the coordinate points. 
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 A qualitative velocity graph of the arch cross-section, as seen in Figure 42, shows 
a streamline within the center of the arch of the maximum velocity.  The color gradient 
depicts the velocities within the arch. 
 
Figure 43. Cross-sectional plot of the arch velocity. 
 
The interior of the arch has the highest velocity with lower velocities towards the walls 
and the thoracic aorta outlet of the arch. Another qualitative result is seen in Figure 43, 
showing an arrow plot of the velocities within the arch. 
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Figure 44. Arrow plot depicting velocities within the arch. 
 
The arrow plot depicts the direction and magnitude of the fluid within the arch and notes 
the maximum and minimum velocities within the arch. As expected, the maximum 
velocity is at the centerline of the vessel and the minimum velocity is at the vessel wall. 
 
4.3 Comparative Results 
 The following graphs show the three experimental trials plotted in comparison to 
the equivalent COMSOL MultiPhysics® coordinates. As previously mentioned, the 
experimental velocities were calculated by measuring the distance between the furthest 
downstream point of dye in one frame to the furthest downstream point of dye in the 
preceding frame. The distance was divided by the time between frames and represents the 
 
 
60 
average velocity at the furthest point. The velocities from the COMSOL MultiPhysics® 
model were calculated using the average velocity from an array of point evaluations at 
the same coordinates as the dye point in the physical model. The point positions used in 
the graphs were assigned as an integer based on the sequence of occurrence within the 
trial. 
 As seen in Figure 44, Trial 1 differed the most in velocity at the first point 
position with a higher experimental velocity, but was otherwise consistent. 
 
 
Figure 45. Scatter plot of Trial 1 comparing the COMSOL MultiPhysics® and experimental velocities. 
 
 As seen in Figure 45, Trial 2 differed at the first coordinate point with a higher 
experimental velocity. Otherwise, the experimental velocities were less than the 
COMSOL MultiPhysics® velocities. 
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Figure 46. Scatter plot of Trial 2 comparing the COMSOL MultiPhysics® and experimental velocities. 
 
As seen in Figure 46, in Trial 3 the first dye point was very similar. As the dye 
front moved through the vessel, the experimental velocities were less than the COMSOL 
MultiPhysics® velocities. 
 
Figure 47. Scatter plot of Trial 3 comparing the COMSOL MultiPhysics® and experimental velocities. 
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4.4 Statistical Comparison 
 The statistical analysis comparing the physical model results and the COMSOL 
MultiPhysics® results was calculated using a Paired 2-Sample T-Test in JMP. For this 
study, alpha was set to 0.05, the confidence interval was set to 95%, and the alternative 
hypothesis denotes a significant difference in the samples. The output, as seen in Figure 
47, has a p-value of 0.1058 which is greater than 0.05; therefore, we fail to reject the null 
hypothesis as there is not significant statistical evidence to conclude a difference between 
the physical model velocities and the COMSOL MultiPhysics® model velocities.  
 
 
Figure 48.  The JMP statistical analysis showing no significant difference between the experimental and 
COMSOL MultiPhysics® values.
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CHAPTER 5: DISCUSSION 
5.1 Interpretation of the Experimental Model 
 One aspect of this study was to create a three-dimensional, physiologically 
accurate construct of the aortic arch using additive manufacturing techniques for the 
purpose of clinical testing. The methods developed in this study used to create a physical 
model were effective and met the purpose of the study. The construction of the model 
utilized widely available 3D printing to maintain a physiologically accurate 
representation of a patient anatomy. All support material was removed in the process and 
the cavity within the model was an accurate representation of the intended STL file. The 
selected material for the model was transparent and did not become damaged during 
experimentation.  
This model could be used in a clinical setting or in a research and development 
setting. One application would be to use CT scans from difficult patient anatomy to 
create new models; the subsequent model could be used as a training tool for surgeons to 
practice the use and deployment of medical devices within the aortic arch. The purpose 
would be to reduce surgical error and improve the adoption of new medical devices. 
Another application would be to use the model to test a medical device while in the 
development or validation stage. The model can be used to help visualize the sequence of 
use of the device and be incorporated into quantitative evaluation, as will be further 
elaborated on in Section 5.2.    
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5.2 Interpretation of the COMSOL MultiPhysics® Model and Comparison Study 
 The COMSOL MultiPhysics® model had two purposes: to iterate on the work by 
Andrew Janicki and to serve as a comparator to the physical model. The primary 
improvements on Janicki’s model were the increased STL file mesh size and the accuracy 
of flow conditions within the arch. The studies by David Baik and Brandon Cohen, as 
undergraduates contributing to this study, utilized MeshMixer and SolidWorks to 
increase the number of faces on the model. Additionally, in COMSOL MultiPhysics® 
studies, a significant difference was shown between Janicki’s model and Baik’s model 
when using laminar flow. The findings from these studies were incorporated into the 
comparator study that was used to validate the experimental model. (Refer to external 
reports for more detail on Baik and Cohen’s studies.) 
 The qualitative COMSOL MultiPhysics® outputs, specifically the velocity and 
arrow plots, showed higher velocity towards the center of the vessel and lower velocities 
towards the edges of the vessel. This result is accurate in accordance with the Hagen-
Pouiselle equation and is as expected to have a maximum velocity in the center 
streamline of the vessel [N]. The qualitative graphs also demonstrated a lower velocity in 
the fluid after the outlets of the three branching vessels. This is likely due to the loss of 
fluid from those outlets, resulting in lower fluid flow in the remainder of the vessel and 
therefore a lower flow rate and velocity.  
 The scatter plot graphs depicting the experimental velocities in comparison to the 
COMSOL MultiPhysics® velocities had a few qualitative inconsistencies. At the first 
data point for all three trials, the experimental value was equivalent or lower to the 
COMSOL MultiPhysics® value. This discrepancy could be due to the lack of uniform 
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flow at the entrance of the vessel. While the diameter of the tubing from the pump 
matched the diameter of the inlet, uniform flow and velocity within the arch could not be 
guaranteed at the inlet. The fluid flow may have been faster in certain aspects of the inlet 
of the model, causing the higher velocity in the experimental model. The remainder of the 
data points, across all three trials, had lower experimental velocities than the COMSOL 
MultiPhysics® velocities. This could be due to a discrepancy of the inlet velocity 
location; while the measured velocity was equivalent to the initial COMSOL 
MultiPhysics® condition, the planar slicing in SolidWorks removed a portion of the 
bottom of the arch in the COMSOL MultiPhysics® model and moved the fluid inlet 
further up the arch. While not much of the arch was removed, the change could have 
increased the velocity throughout the COMSOL MultiPhysics® simulation.  
While the results differed slightly, the statistical analysis of the COMSOL 
MultiPhysics® simulation velocities in comparison to the physical model velocities 
confirmed the accuracy of the in silico study. As there was no statistically significant 
difference between the empirical and in silico models, the study showed that the 
conditions created within a physical, anatomically accurate model can be emulated using 
a computer model. While a physical model is useful for various reasons, a computer 
model uses fewer resources to create, reduces computational steps, and can output more 
values from a single study. For instance, the COMSOL MultiPhysics® model could also 
be used to visualize the magnitude and direction of the velocity, as seen in the arrow plot, 
or output the shear stress in an area of the vessel.  
This validation of the accuracy of the COMSOL MultiPhysics® model makes it 
applicable to medical device testing. The Food and Drug Administration (FDA) is the 
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regulatory body within the United States responsible for the approval and clearance of 
medical devices and procedures [43]. The FDA recognizes computational models, such 
as finite element analysis, as a tool to evaluate the safety and effectiveness of medical 
devices. An FDA guidance document is publicly available for the submission of 
“Computational Fluid Dynamics and Mass Transport”, outlining the requirements for the 
submission of a computational model. Those requirements include and are not limited to 
descriptions of the system geometry, governing equations, system properties, boundary 
and initial conditions, and validation [45], aspects that were all met within this study. 
There are a variety of methods available to validate computational models, with no 
specific protocol yet defined within the medical community. Within computer modeling, 
validation is the “substantiation that a computerized model within its domain of 
applicability possesses a satisfactory range of accuracy consistent with the intended 
application of the model.” (Schlesinger et  al. 1979) [47]. The validation method within 
this study used a real world system to statistically validate a finite element analysis model 
and could hypothetically meet FDA requirements for submission. 
An example of the value of FEA analysis is with a device for intervertebral body-
fusion devices (IBFDs). The FDA required the company to test all of the products for 
different areas of the spine, despite having very similar designs and variations to match 
patient anatomy. The physical testing would have cost the company $1.2 million, making 
the project uneconomical. The company was able to show that the weakest IBFD, in 
terms of FDA testing criteria, could still pass FDA standards using FEA modeling. With 
computer modeling, the company was able to reduce the time, cost, and risk associated 
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with full-scale testing of the product and bring the product to market within the United 
States [46]. 
In the example of Claret’s Sentinel CPS, the use of FEA and the validation of the 
computer model could be applicable in using COMSOL MultiPhysics® for particle 
tracking. As the company is developing the device and submitting for FDA approval, 
there is a need for quantitative evidence that the device removes particles from the 
vessels branching to the cerebral system. As shown in Janicki’s study, COMSOL 
MultiPhysics® has the functionality to track particles within geometries. By combining 
the validation of this study and the improved parameters of Janicki’s study, particle 
tracking could be performed in COMSOL MultiPhysics® to show the effectiveness of the 
device while reducing the cost and time associated with physical models. 
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CHAPTER 6: SUMMARY & CONCLUSIONS 
6.1 Contributions to Biomedical Engineering 
The results of this study contributed to the field of biomedical engineering by 
creating a method of application for CT scans, further establishing a novel technique of 
flow visualization, and successfully performing in silico validation. The creation of a full 
vessel model is useful for both engineers and clinicians. While there are vendors that 
make vessel models, this technique was done with limited equipment and a budget of 
approximately $350. It could very easily be applied to different geometries and be used 
as an in house method of creating new models, for reasons previously mentioned. This 
study also utilized a method of flow visualization recently developed in two previous 
studies; by further developing the method, two of the three studies have now successfully 
used this method of flow visualization to validate a computational model. Finally, the 
validation of the in silico model contributed to the field of biomedical engineering by 
establishing a protocol and potentially contributing to the test methods of Claret Medical.  
 
6.2 Study Limitations 
While the study was successful, there were limitations associated with the 
physical model and computer model. Limitations of the physical model include the seam 
between the two halves and the step sizes from 3D printing. While efforts were taken to 
mitigate this issues, including using a resin to fill in the step-sizes and bonding with the 
optimal technique, ridges were still present in the model that were not present in the 
COMSOL MultiPhysics® model and may have altered the fluid flow within the arch. 
During experimentation the model was interchanged with multiple inlet and outlet press-
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fit tubes, which caused a slight separation of the two halves. Further damage was stopped 
by using a C-clamp to hold the halves together. In the future, this can be mitigated by 
measuring the inlet and outlets of the model to not exceed the size while press-fitting 
attachments. For the experimental set-up, additional lighting should be used to better 
visualize the arch. A significant limitation was that a uniform velocity could not be 
achieved at the inlet and the presence of bubbles in the model. While efforts were taken 
to limit these factors, further methods should be developed to improve the uniformity of 
inlet velocity and decrease frequency of bubbles.  
Within the COMSOL MultiPhysics® model, as with all finite element 
simulations, there were limitations of the accuracy of the simulation. The program 
required a simplification of the original geometry to be able to process the file size. The 
mesh size that was used had the highest number of elements possible with the file size, as 
finer mesh sizes caused the program and simulation to crash. Another limitation was that 
the version of COMSOL MultiPhysics® used, COMSOL MultiPhysics® 4.4, lacked the 
ability to define distinct coordinates. The coordinates of the origin point were obtained 
through a study run with the same geometry and parameters. The study was equivalent, 
but had to be run prior to the comparison study, as the program version did not have the 
capability of displaying coordinates. Finally, the discrepancy of the COMSOL 
MultiPhysics® inlet location in comparison to the physical model inlet location may have 
caused a change in velocity throughout the model. In future studies, the planar cuts 
should be included in both models to eliminate the change of inlet position. 
For the overall study, the significant limitations were associated with simulating 
in vivo conditions. The pressure was not controlled at the inlet and outlet and was 
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atmospheric in this study; this would not be the case in vivo as there are different 
pressures within the body. A second aspect is that pulsatile flow would better mimic 
blood flow within the body, but was outside the scope of this study. Similarly, water was 
used to simulate fluid in this model for budget and scope reasons. Blood, or a fluid with 
similar properties, would better emulate physiologic conditions for testing. Finally, the 
geometry used in this study was a simplified model of real patient anatomy. An 
assumption of this study is that the simplification of the model maintained the significant 
characteristics of the anatomical features. 
 
6.3 Future Work and Conclusions 
 Transcatheter aortic valve replacement is a developing minimally invasive 
procedure and is very relevant in the medical field. As TAVR and similar procedures 
continue to develop, the need for experimental evaluation and visualization of devices 
will continue to grow, making this project relevant to many companies in the medical 
device industry. In future iterations of this study, fluid with physiologically accurate 
properties should be incorporated. Blood is a non-Newtonian fluid, which could change 
the results of the model. Incorporating a fluid similar to blood would better mimic 
conditions in the body for device testing. Additionally, different patient scans could be 
used to emulate difficult anatomies. Within the computer model, different anatomies 
could be compared to determine if fluid flow differs and in what way. Within the physical 
model, the model could be extended to include inlets for medical devices and the model 
could be used as a training device for physicians in difficult anatomies. Finally, all the 
studies of Janicki should be repeated with the improvements indicated in this study and in 
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the reports of Baik and Cohen. Additionally, the limitations of this study should be taken 
into consideration and mitigated.  
In conclusion, this study used CT scans from Claret Medical to create an 
anatomically accurate physical model and improve an existing computational model. The 
computational model was successfully validated using a novel technique of flow 
visualization. The validation of the computational model is applicable to TAVR 
procedures and the method could be applicable for different anatomies and other 
procedures within the aortic arch. 
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APPENDICES 
Appendix A: MeshMixer Processing of the STL File 
Written by Brandon Cohen 
 
 This is a protocol on how to transform a CT scanned part into a part that can be 
opened and manipulated in SolidWorks. This is important when 3D printing of the part is 
necessary, for if the part is too large of a mesh, it can not be opened in SolidWorks and 
many other 3D programs. This protocol uses Autodesk MeshMixer, SourceForge 
Meshlab, and Netfabb Basic to accurately cleanup the part, minimize the mesh size, and 
prepare it for exporting into SolidWorks. All three of these programs are freeware, and 
download links are supplied below.  
Autodesk MeshMixer 
 Autodesk MeshMixer is free software used for altering STL files. Download 
MeshMixer at http://www.meshmixer.com/download.html.  
NOTE: Since MeshMixer is a free tool, it is prone to crashing. Save early and often. Get 
into the habit of saving after every change is made. 
Import .STL file into Autodesk MeshMixer: 
1. File à Import à Select file 
a. You can also import by clicking Import in the top left panel (giant “+”) 
2. Once Imported, your part will be shown like below. Notice in the bottom right 
corner of MeshMixer the number of vertices and triangles of the part is 
shown. This is important to keep in mind, for SolidWorks can generally 
handle up to 10,000-11,500 triangles (or faces).   
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Smooth the Part as a Whole: 
1. Choose Select (on left panel) à double-click part to select entire part (notice it 
changes color, in this case orange) 
2. Deform à Smooth 
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3. Keep Smooth settings as shown (notice the part is now shown as a preview of 
what it will look like if these settings are accepted) 
4. Accept 
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Reduce the Mesh Size (decrease triangle count) 
1. Select à double-click part to select entire part 
2. Edit à Reduce  
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3. Select how you want to reduce the mesh size (‘Reduce Target’). This can be done 
in three ways: Percentage, Triangle Budget, and Max Deviation. It is 
recommended to use Percentage or Triangle Budget. Once an option is chosen, 
ensure that ‘Reduce Type’ is set to ‘Shape Preserving’. 
4. Use the appropriate slider (slider associated with ‘Reduce Target’ that has been 
chosen) to adjust the part mesh size. Again, the part will change and show a 
preview of what it will look like prior to accepting the change. 
5. Recommended to use Percentage reduce target initially, and change the 
Percentage slider to 70%. 
6. Accept 
a. Notice that the Triangle Count of the part decreases (lower right corner). 
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Cleaning up/Smoothing out Specific Sections: 
1. Select à click on area of interest (this can be done by clicking on a specific area, 
or click and hold to paint a certain area). The selection brush size can be changed, 
by adjusting the ‘Size’ slider under ‘Select’ tab. The area that has been selected 
and will be modified is now a different color (orange). 
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2. Edit à Erase & Fill
 
3. Leave default settings. Again, a preview of the change is shown prior to accepting 
the change. 
4. Accept 
5. Clear Selection to deselect the area of the part that was just altered 
6. Repeat for all areas of interest that need to be smoothed out 
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Removing Sections of the Part: 
1. Select à select area of interest (notices it changes color)  
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2. Edit à Discard 
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Removing Sections of the Part: Troubleshooting  
1. If there are “floating meshes” still present after removing the section of interest, 
they can be removed by performing the same steps as above (clicking on 
individual triangles) or by this method (selecting by drawing around the floating 
triangles).  
 
2. Select à instead of clicking on individual triangles, draw a circle around the 
floating triangles by clicking and holding down the mouse. You will see where 
you are drawing with the red line left from your cursor. Ensure that you close up 
your loop around the floating triangles. NOTE: Before moving to the next step, 
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make sure you did not accidentally select any other areas of the part (zoom out 
and examine the part for a change in color, indicating part selection).  
 
3. Edit à Discard  
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NOTE: If you have accidentally removed more than you wanted, you can undo the last 
action by going to Action à Undo|Back (or Ctrl+z). 
 
Filling a Hole using MeshMixer: 
1. Select à Select area around the hole you desire to fill 
2. Edit à Erase & Fill  
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3. Check the preview of how MeshMixer will fix the section. If you like the 
preview, click Accept 
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NOTE: It can be challenging to fill holes exactly how you would like them to be filled in 
MeshMixer. Later on in the process, NetFab Basic is used to again check for holes, and 
will repair the part (fill all holes). However, NetFab Basic does not allow for any control 
on how the holes are filled, so it is recommended to attempt to fill holes using 
MeshMixer for it allows more control on the shape the part will take. 
 
Separating Sections in MeshMixer: 
1. To separate sections in MeshMixer, Selectà highlight section you wish to 
remove  
 
 
90 
 
2. Edit à Separate. 
 NOTE: Once you click Separate, the highlighted region will become its own 
section (own piece in the object browser window). There is no preview or accept 
button associated with Separate, so if you made an error in the section you wanted 
to separate, use Action à Undo|Back (or Ctrl+z) to remove the change. 
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3. The section is now its own object in the object browser. To delete this section, 
ensure that you have just this section selected (rest of the part is dimmed when 
only one object is selected), and click the trash can ‘Delete’ button in the bottom 
right of the Object Browser. 
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Final Triangle Size Check: 
1. Prior to exporting the part, double check the number of triangles in the mesh 
(bottom right corner of MeshMixer window). SolidWorks can generally handle 
10,000-11,500 triangles. If you are not in this range, you can reduce the mesh size 
by using a ‘Triangle Budget’ reduction. This is better to do once your part is near 
the range required (10,000-11,500), for it will not drastically alter the shape and 
“cleanliness” of the part.  
2. To reduce the mesh size further, Select à select entire part (double click part) 
3. Edit à Reduce 
4. Change “Reduce Target” to “Triangle Budget”. The “Tri Count” slider is now 
able to be changed. 
5. Side to desired mesh triangle count. A preview of the part is shown. Click Accept 
if the changes are desired. 
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Exporting Part for Mesh Count Check: 
1. File à Export 
2. Save it as a “.PLY” file type. Save it in the location of your choice. Remember 
where the file is saved for ease of locating it for further use.  
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SourceForge Meshlab 
 Meshlab is another free software that can be used to manipulate parts for 3D 
printing. Download Meshlab at http://meshlab.sourceforge.net/ 
Exact Mesh Count in Meshlab: 
1. File à Import Mesh 
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2. Locate and select the part file of interest. 
3. Filters à Remeshing, Simplification, and Reconstruction à Quadratic Edge 
Collapse Decimation 
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4. Enter your Target Number of Faces (10,000 in this example). Keep the other 
number options as the defaults (shown in following image). Check the following 
boxes: Preserve Normal, Preserve Topology, Optimal position of simplified 
vertices, and Post-simplification cleaning. 
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5. Apply. Notice that in the bottom purple bar, the number of faces now reflects the 
target number you entered previously.  
6. File à Export Mesh As… export the mesh as a “.PLY” in order to be imported 
into Netfabb Basic for repair/hole checking. Be sure to remember where you 
saved the exported file. 
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Netfabb Basic 
 Netfabb Basic is free software used for cleanup of STL files. Download at 
http://www.netfabb.com/downloadcenter.php?basic=1  
Repairing the Part: 
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1. Open Netfabb Basic. This registration popup screen will appear. Select “I accept 
the terms of usage” and click Later. 
 
2. Project à Add Part. Locate and select your part. 
 
 
101 
 
3. When your part is loaded into Netfabb Basic, it checks it for any holes in the part. 
If there are holes present, there will be a warning triangle in the lower right corner 
of the window. Additionally, the holes will be shown in red on the part. NOTE: 
Even if you load your part, and there are no red locations on it and no warning in 
the bottom right corner, you should still follow the rest of this repair step to 
ensure your part loads properly in SolidWorks. 
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4. Click on the Red Cross in the top toolbar (Repair button).  
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5. The part now changes color, and shows all of the individual triangles. On the right 
toolbar, leave all of the repair settings at the defaults. Click Automatic Repair in 
the bottom of the right toolbar. 
 
6. Select Default Repair in the popup window. Click Execute. Then click Apply 
Repair on the right toolbar. 
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7. Click Remove Old Part in the next popup window. The part is now shown green 
again, and there is no warning triangle in the bottom right of the window. Your 
part is now ready for exporting. 
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8. Part à Export Part à as STL 
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9. Your part is now saved as a repaired STL, and can be opened in SolidWorks. If 
after selecting export this warning popup appears, click Optimize. The warning 
triangle now becomes a green checkmark. Click Export.  
 
 
 
 
Opening Part in SolidWorks: 
1. Open SolidWorks 
2. Open your part (filter to .STL files) 
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3. Accept the Import Diagnostics (click Yes) 
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4. The part should now be imported into SolidWorks as a solid part. The message 
box on the left of the import diagnostics window should be green and read “No 
faulty faces or gaps remain in the geometry.”  
 
Click the Green Checkmark. Your part is now a solid part and can be modified using 
SolidWorks.   
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Appendix B: 3D Printer Basic and Advanced Settings 
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Appendix C: Inlet Velocity Calculations 
 
Average measured inlet flow rate: 13.737 seconds per liter 
 1	𝐿𝑖𝑡𝑒𝑟13.737	𝑠𝑒𝑐𝑜𝑛𝑑𝑠 ∗ 	60	𝑠𝑒𝑐𝑜𝑛𝑑𝑠1	𝑚𝑖𝑛𝑢𝑡𝑒 = 4.367	𝐿𝑖𝑡𝑒𝑟𝑠/𝑚𝑖𝑛𝑢𝑡𝑒 
 𝑄 = 𝑉 ∗ 𝐴 
(4.367	𝐿𝑖𝑡𝑒𝑟𝑠60	𝑆𝑒𝑐𝑜𝑛𝑑𝑠 ∗ 	 1	𝑚𝑒𝑡𝑒𝑟y10000	𝐿𝑖𝑡𝑒𝑟𝑠) = 𝑉 ∗ (𝜋 ∗ (0.0127	𝑚𝑒𝑡𝑒𝑟𝑠)|) 
 𝑉 = 0.1436	𝑚𝑒𝑡𝑒𝑟𝑠	𝑝𝑒𝑟	𝑠𝑒𝑐𝑜𝑛𝑑 
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Appendix D: ImageJ Processing Methods 
1) Setting the image scale: 
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2) Adjusting image threshold and measure pixel path length from the origin: 
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3) Measuring the model’s angle of rotation: 
 
 
116 
Appendix E: Example Images of Dye Trial 1 
Raw Images: 
Trial 1, Frame 8 
 
Trial 1, Frame 18 
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Trial 1, Frame 28 
 
 
Trial 1, Frame 38 
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Trial 1, Frame 48 
 
Trial 1, Frame 58 
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Trial 1, Frame 68 
 
Images with threshold from ImageJ: 
  
Trial 1, Frame 8, Threshold 
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Trial 1, Frame 18, Threshold 
 
 
Trial 1, Frame 28, Threshold 
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Trial 1, Frame 38, Threshold 
 
 
Trial 1, Frame 48, Threshold 
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Trial 1, Frame 58, Threshold 
 
 
Trial 1, Frame 68, Threshold 
